All Stories

  1. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Article • Nature Medicine, October 2023, Springer Science + Business Media

    Jordi Carratalà

  2. Prolonged vs short-term infusion of β-lactam antibiotics for the treatment of febrile neutropenia: A systematic review and meta-analysis

    Article • Journal of Infection, September 2023, Elsevier

    Jordi Carratalà

  3. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    Article • American Journal of Transplantation, July 2023, Elsevier

    Jordi Carratalà

  4. Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study

    Article • Antibiotics, June 2023, MDPI AG

    Jordi Carratalà

  5. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci

    Article • Clinical Infectious Diseases, June 2023, Oxford University Press (OUP)

    Jordi Carratalà

  6. Executive summary – Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), th...

    Article • Atención Primaria, June 2023, Elsevier

    Jordi Carratalà

  7. Impact of a prospective audit and feedback antimicrobial stewardship programme on carbapenem consumption: a quasi-experimental study (IPANEMA study)

    Article • Journal of Antimicrobial Chemotherapy, May 2023, Oxford University Press (OUP)

    Jordi Carratalà

  8. Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

    Article • BMC Infectious Diseases, May 2023, Springer Science + Business Media

    Jordi Carratalà

  9. Dynamics of Gene Expression Profiling and Identification of High-Risk Patients for Severe COVID-19

    Article • Biomedicines, May 2023, MDPI AG

    Jordi Carratalà

  10. Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study

    Article • Frontiers in Cellular and Infection Microbiology, April 2023, Frontiers

    Jordi Carratalà

  11. Changing Trends in the Global Consumption of Treatments Used in Hospitalized Patients for COVID-19: A Time Series Multicentre Study

    Article • Antibiotics, April 2023, MDPI AG

    Jordi Carratalà

  12. Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients

    Article • Antibiotics, March 2023, MDPI AG

    Jordi Carratalà

  13. Executive summary. Diagnosis, treatment and prophylaxis of influenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the S...

    Article • Anales de Pediatría (English Edition), March 2023, Elsevier

    Jordi Carratalà

  14. Increasing Gram-Negative Catheter-Related Bloodstream Infection in Cancer Patients

    Article • Pathogens, February 2023, MDPI AG

    Jordi Carratalà

  15. Executive summary. Diagnosis, treatment and prophylaxis of influenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the ...

    Article • Enfermedades infecciosas y microbiologia clinica (English ed ), February 2023, Elsevier

    Jordi Carratalà

  16. Whole-Blood Gene Expression Profiles Associated with Mortality in Community-Acquired Pneumonia

    Article • Biomedicines, February 2023, MDPI AG

    Jordi Carratalà

  17. Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study

    Article • Journal of Infection, February 2023, Elsevier

    Jordi Carratalà

  18. Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study

    Article • Infectious Diseases and Therapy, December 2022, Springer Science + Business Media

    Jordi Carratalà

  19. Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

    Article • December 2022, Research Square

    Jordi Carratalà

  20. Effect of positive microbiological testing on antibiotic de-escalation and outcomes in community-acquired pneumonia: a propensity score analysis

    Article • Clinical Microbiology and Infection, December 2022, Elsevier

    Jordi Carratalà

  21. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Article • Transplantation, October 2022, Wolters Kluwer Health

    Jordi Carratalà

  22. Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter study

    Article • PLoS ONE, October 2022, PLOS

    Jordi Carratalà

  23. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

    Article • Annals of Internal Medicine, October 2022, American College of Physicians

    Jordi Carratalà

  24. Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors

    Article • Pathogens, September 2022, MDPI AG

    Jordi Carratalà

  25. Autoantibodies against type I IFNs in patients with critical influenza pneumonia

    Article • The Journal of Experimental Medicine, September 2022, Rockefeller University Press

    Jordi Carratalà

  26. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Article • Open Forum Infectious Diseases, August 2022, Oxford University Press (OUP)

    Jordi Carratalà

  27. Genotypic and Phenotypic Study of Antiviral Resistance Mutations in Refractory Cytomegalovirus Infection

    Article • The Journal of Infectious Diseases, August 2022, Oxford University Press (OUP)

    Jordi Carratalà

  28. Effect of Undernutrition and Obesity on Clinical Outcomes in Adults with Community-Acquired Pneumonia

    Article • Nutrients, August 2022, MDPI AG

    Jordi Carratalà

  29. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

    Article • Microbiology Spectrum, June 2022, ASM Journals

    Jordi Carratalà

  30. Risk Factors and Outcomes of Acute Graft Pyelonephritis with Bacteremia Due to Multidrug-Resistant Gram-Negative Bacilli among Kidney Transplant Recipients

    Article • Journal of Clinical Medicine, June 2022, MDPI AG

    Jordi Carratalà

  31. Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis

    Article • Medical Mycology, June 2022, Oxford University Press (OUP)

    Jordi Carratalà

  32. Causative Agents of Ventilator-Associated Pneumonia and Resistance to Antibiotics in COVID-19 Patients: A Systematic Review

    Article • Biomedicines, May 2022, MDPI AG

    Jordi Carratalà

  33. Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies

    Article • Open Forum Infectious Diseases, May 2022, Oxford University Press (OUP)

    Jordi Carratalà

  34. Impact of the coronavirus disease 2019 (COVID-19) pandemic on infection control practices in a university hospital

    Article • Infection Control and Hospital Epidemiology, May 2022, Cambridge University Press

    Jordi Carratalà

  35. Legionnaires’ Disease: Update on Diagnosis and Treatment

    Article • Infectious Diseases and Therapy, May 2022, Springer Science + Business Media

    Jordi Carratalà

  36. The Effectiveness of Combination Therapy for Treating Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Literature Review and a Meta-Analysis

    Article • Microorganisms, April 2022, MDPI AG

    Jordi Carratalà

  37. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia

    Article • Microorganisms, March 2022, MDPI AG

    Jordi Carratalà

  38. Ceftolozane/tazobactam for difficult‐to‐treat Gram‐negative infections: A real‐world tertiary hospital experience

    Article • Journal of Clinical Pharmacy and Therapeutics, March 2022, Hindawi Publishing Corporation

    Jordi Carratalà

  39. Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

    Article • Journal of Antimicrobial Chemotherapy, February 2022, Oxford University Press (OUP)

    Jordi Carratalà

  40. Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock

    Article • Antimicrobial Agents and Chemotherapy, February 2022, ASM Journals

    Jordi Carratalà

  41. Infective Endocarditis: New Challenges in a Classic Disease

    Article • Seminars in Respiratory and Critical Care Medicine, February 2022, Thieme Publishing Group

    Jordi Carratalà

  42. Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort

    Article • Biomedicine & Pharmacotherapy, February 2022, Elsevier

    Jordi Carratalà

  43. Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review

    Article • Mycoses, January 2022, Wiley

    Jordi Carratalà

  44. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Article • Nutrients, December 2021, MDPI AG

    Dr Mikhail F. Borisenkov, Fernando Fernandez-Aranda, Jordi Carratalà, Roser Granero

  45. Bloodstream Infection and Endocarditis Caused by Staphylococcus aureus in Patients with Cancer: A Multicenter Cohort Study

    Article • Infectious Diseases and Therapy, December 2021, Springer Science + Business Media

    Jordi Carratalà

  46. Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain

    Article • Frontiers in Endocrinology, November 2021, Frontiers

    Fernando Fernandez-Aranda, Jordi Carratalà

  47. Long-term impact of COVID-19 associated acute respiratory distress syndrome

    Article • Journal of Infection, November 2021, Elsevier

    Jordi Carratalà

  48. Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case–control matched multicentre study (BACTCOVID)

    Article • Clinical Microbiology and Infection, November 2021, Elsevier

    Jordi Carratalà

  49. Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines

    Article • Microorganisms, October 2021, MDPI AG

    Jordi Carratalà

  50. Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing Enterobacterales in Kidney Transp...

    Article • Antimicrobial Agents and Chemotherapy, October 2021, ASM Journals

    Jordi Carratalà

  51. Economic impact of a care bundle to prevent surgical site infection after craniotomy: a cost-analysis study

    Article • Antimicrobial Resistance and Infection Control, October 2021, Springer Science + Business Media

    Jordi Carratalà

  52. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*

    Article • Critical Care Medicine, October 2021, Wolters Kluwer Health

    Jordi Carratalà

  53. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

    Article • Intensive Care Medicine, October 2021, Springer Science + Business Media

    Jordi Carratalà

  54. Infectious diseases experts as part of the antibiotic stewardship team in primary care: protocol for a cluster-randomised blinded study (IDASP)

    Article • BMJ Open, October 2021, BMJ

    Jordi Carratalà

  55. Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study

    Article • Journal of Infection, September 2021, Elsevier

    Jordi Carratalà

  56. Multicentre, randomised, open-label, phase IV–III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptibleStaphylococcus ...

    Article • BMJ Open, August 2021, BMJ

    Jordi Carratalà

  57. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Article • Infectious Diseases and Therapy, July 2021, Springer Science + Business Media

    Jordi Carratalà

  58. Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study)

    Article • Antimicrobial Agents and Chemotherapy, July 2021, ASM Journals

    Jordi Carratalà

  59. One air, one health: air pollution in the era of antimicrobial resistance

    Article • Clinical Microbiology and Infection, July 2021, Elsevier

    Jordi Carratalà

  60. Immunological imprinting of the antibody response in COVID-19 patients

    Article • Nature Communications, June 2021, Springer Science + Business Media

    Jordi Carratalà

  61. Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?

    Article • European Journal of Drug Metabolism and Pharmacokinetics, June 2021, Springer Science + Business Media

    Jordi Carratalà

  62. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    Article • The Lancet Infectious Diseases, June 2021, Elsevier

    Jordi Carratalà

  63. Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies

    Article • Open Forum Infectious Diseases, May 2021, Oxford University Press (OUP)

    Jordi Carratalà

  64. Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study

    Article • PLoS ONE, April 2021, PLOS

    Dr. Jerónimo Pachón, Jordi Carratalà

  65. Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance

    Article • Frontiers in Medicine, March 2021, Frontiers

    Jordi Carratalà

  66. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Article • Open Forum Infectious Diseases, March 2021, Oxford University Press (OUP)

    Jordi Carratalà

  67. Risk factors for hospital readmission following complicated urinary tract infection

    Article • Scientific Reports, March 2021, Springer Science + Business Media

    Jordi Carratalà

  68. Risk factors for enterococcal urinary tract infections: a multinational, retrospective cohort study

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 2021, Springer Science + Business Media

    Jordi Carratalà

  69. Asymptomatic bacteriuria in kidney transplant recipients: to treat or not to treat—that is the question

    Article • Clinical Microbiology and Infection, March 2021, Elsevier

    Jordi Carratalà

  70. SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load

    Article • Journal of Infection, March 2021, Elsevier

    Jordi Carratalà

  71. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score

    Article • Thorax, February 2021, BMJ

    Jordi Carratalà

  72. Current Challenges in the Management of Infective Endocarditis

    Article • Frontiers in Medicine, February 2021, Frontiers

    Jordi Carratalà

  73. Risk of acute deterioration and care complexity individual factors associated with health outcomes in hospitalised patients with COVID-19: a multicentre cohort study

    Article • BMJ Open, February 2021, BMJ

    Jordi Carratalà

  74. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Article • Clinical Microbiology and Infection, February 2021, Elsevier

    Jordi Carratalà

  75. Effects of age and comorbidities on serum levels of inflammatory markers in community‐acquired pneumonia

    Article • European Journal of Clinical Investigation, January 2021, Wiley

    Jordi Carratalà

  76. Efficacy of β‐lactam/β‐lactamase inhibitors to treat extended‐spectrum beta‐lactamase‐producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT‐SOT Project)

    Article • Transplant Infectious Disease, January 2021, Wiley

    Jordi Carratalà

  77. Role of the inflammatory response in community-acquired pneumonia: clinical implications

    Article • Expert Review of Anti-infective Therapy, January 2021, Taylor & Francis

    Jordi Carratalà

  78. Why should quality metrics be used for infectious disease assessment, management and follow up in solid organ transplantation?

    Article • Clinical Microbiology and Infection, January 2021, Elsevier

    Jordi Carratalà

  79. Prognostic and predictive biomarkers in patients with COVID-19 treated with tocilizumab in a randomised controlled trial

    Article • December 2020, Cold Spring Harbor Laboratory Press

    Jordi Carratalà

  80. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    Article • Cell Reports Medicine, November 2020, Elsevier

    Jordi Carratalà

  81. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Article • Clinical Microbiology and Infection, November 2020, Elsevier

    Jordi Carratalà

  82. Host- and Pathogen-Related Factors for Acute Cardiac Events in Pneumococcal Pneumonia

    Article • Open Forum Infectious Diseases, October 2020, Oxford University Press (OUP)

    Jordi Carratalà

  83. Antibody Immunological Imprinting on COVID-19 Patients

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Jordi Carratalà

  84. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

    Article • Frontiers in Immunology, October 2020, Frontiers

    Jordi Carratalà

  85. Reply to Pacios-Martínez and García-Monzón

    Article • Clinical Infectious Diseases, October 2020, Oxford University Press (OUP)

    Jordi Carratalà

  86. Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of D...

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2020, Elsevier

    Jordi Carratalà

  87. COVID Isolation Eating Scale ( CIES ): Analysis of the impact of confinement in eating disorders and obesity—A collaborative international study

    Article • European Eating Disorders Review, September 2020, Wiley

    Dr Mikhail F. Borisenkov, Fernando Fernandez-Aranda, Jordi Carratalà, Roser Granero

  88. Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial—a trial protocol

    Article • Trials, August 2020, Springer Science + Business Media

    Jordi Carratalà

  89. Effects of age and comorbidities on inflammatory markers in community-acquired pneumonia

    Article • August 2020, Research Square

    Jordi Carratalà

  90. Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol

    Article • BMJ Open, August 2020, BMJ

    Jordi Carratalà

  91. Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern

    Article • Infection Control and Hospital Epidemiology, July 2020, Cambridge University Press

    Jordi Carratalà

  92. Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial

    Article • Clinical Infectious Diseases, July 2020, Oxford University Press (OUP)

    Jordi Carratalà

  93. A Care Bundle Intervention to Prevent Surgical Site Infections After a Craniotomy

    Article • Clinical Infectious Diseases, June 2020, Oxford University Press (OUP)

    Jordi Carratalà

  94. Characteristics and Outcomes of Staphylococcus aureus Bloodstream Infection Originating From the Urinary Tract: A Multicenter Cohort Study

    Article • Open Forum Infectious Diseases, June 2020, Oxford University Press (OUP)

    Jordi Carratalà

  95. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)

    Article • Trials, May 2020, Springer Science + Business Media

    Jordi Carratalà

  96. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)

    Article • April 2020, Research Square

    Jordi Carratalà

  97. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) ...

    Article • Enfermedades Infecciosas y Microbiología Clínica, April 2020, Elsevier

    Jordi Carratalà

  98. Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts

    Article • Critical Care, March 2020, Springer Science + Business Media

    Jordi Carratalà

  99. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa

    Article • Antimicrobial Agents and Chemotherapy, March 2020, ASM Journals

    Jordi Carratalà

  100. Influenza and Bacterial Coinfection in Adults With Community-Acquired Pneumonia Admitted to Conventional Wards: Risk Factors, Clinical Features, and Outcomes

    Article • Open Forum Infectious Diseases, February 2020, Oxford University Press (OUP)

    Jordi Carratalà

  101. Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase‐producing Enterobacterales : The impact of cytomegalovirus disease and lymphopenia

    Article • American Journal of Transplantation, February 2020, Wiley

    Jordi Carratalà

  102. A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients

    Article • Antimicrobial Agents and Chemotherapy, January 2020, ASM Journals

    Jordi Carratalà

  103. An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia

    Article • Journal of Antimicrobial Chemotherapy, December 2019, Oxford University Press (OUP)

    Jordi Carratalà

  104. Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study

    Article • Antimicrobial Resistance and Infection Control, December 2019, Springer Science + Business Media

    Jordi Carratalà

  105. The impact of flushing with pre-filled saline syringes on the incidence of peripheral venous catheter failure: A quasi-experimental study

    Article • The Journal of Vascular Access, November 2019, SAGE Publications

    Jordi Carratalà

  106. Candidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcome

    Article • Transplant Infectious Disease, October 2019, Wiley

    Jordi Carratalà

  107. Optimizing therapy of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae

    Article • Current Opinion in Critical Care, October 2019, Wolters Kluwer Health

    Jordi Carratalà

  108. Is hospital-acquired pneumonia different in transplant recipients?

    Article • Clinical Microbiology and Infection, October 2019, Elsevier

    Jordi Carratalà

  109. Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2019, Elsevier

    Jordi Carratalà

  110. Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis

    Article • BMC Infectious Diseases, August 2019, Springer Science + Business Media

    Jordi Carratalà

  111. Humoral response to natural influenza infection in solid organ transplant recipients

    Article • American Journal of Transplantation, August 2019, Elsevier

    Jordi Carratalà

  112. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing

    Article • PLoS ONE, July 2019, PLOS

    Jordi Carratalà

  113. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection

    Article • The Journal of Infectious Diseases, July 2019, Oxford University Press (OUP)

    Jordi Carratalà

  114. Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized Trial

    Article • Open Forum Infectious Diseases, May 2019, Oxford University Press (OUP)

    Jordi Carratalà

  115. Usefulness of sputum gram stain for etiologic diagnosis in community-acquired pneumonia: a systematic review and meta-analysis

    Article • BMC Infectious Diseases, May 2019, Springer Science + Business Media

    Dr Jorge Acosta-Reyes, Jordi Carratalà

  116. Risk factors for surgical site infection after craniotomy: a prospective cohort study

    Article • Antimicrobial Resistance and Infection Control, May 2019, Springer Science + Business Media

    Jordi Carratalà

  117. Impact of antibiotic resistance on outcomes of neutropenic cancer patients withPseudomonas aeruginosabacteraemia (IRONIC study): study protocol of a retrospective multicentre international study

    Article • BMJ Open, May 2019, BMJ

    Jordi Carratalà

  118. The Impact of Culturing the Organ Preservation Fluid on Solid Organ Transplantation: A Prospective Multicenter Cohort Study

    Article • Open Forum Infectious Diseases, April 2019, Oxford University Press (OUP)

    Jordi Carratalà

  119. Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance

    Article • Clinical Infectious Diseases, April 2019, Oxford University Press (OUP)

    Jordi Carratalà

  120. Impact of β-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score–matched Analysis

    Article • Clinical Infectious Diseases, April 2019, Oxford University Press (OUP)

    Jordi Carratalà

  121. Defining standards of CARE for invasive fungal diseases in solid organ transplant patients

    Article • Journal of Antimicrobial Chemotherapy, March 2019, Oxford University Press (OUP)

    Jordi Carratalà

  122. Urinary antigen testing in community-acquired pneumonia in adults: an update

    Article • Expert Review of Anti-infective Therapy, January 2019, Taylor & Francis

    Jordi Carratalà

  123. Pseudomonas aeruginosa complicated urinary tract infection

    Article • Infection and Drug Resistance, December 2018, Dove Medical Press

    Aina Gomila Grange, Jordi Carratalà

  124. Multistate modelling to estimate excess length of stay and risk of death associated with organ/space infection after elective colorectal surgery

    Article • Journal of Hospital Infection, December 2018, Elsevier

    Dr Elena Espejo, Jordi Carratalà

  125. Usefulness of guideline recommendations for prognosis in patients with candidemia

    Article • Medical Mycology, November 2018, Oxford University Press (OUP)

    Jordi Carratalà

  126. Interventions to decrease short-term peripheral venous catheter-related bloodstream infections: impact on incidence and mortality

    Article • Journal of Hospital Infection, November 2018, Elsevier

    Jordi Carratalà

  127. Extended Infusion of Broad-spectrum β-Lactams in High-risk Febrile Neutropenic Patients

    Article • Clinical Infectious Diseases, October 2018, Oxford University Press (OUP)

    Jordi Carratalà

  128. Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study

    Article • BMC Infectious Diseases, October 2018, Springer Science + Business Media

    Dr Elena Espejo, Jordi Carratalà

  129. Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections

    Article • Antimicrobial Resistance and Infection Control, September 2018, Springer Science + Business Media

    Jordi Carratalà

  130. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    Article • American Journal of Transplantation, August 2018, Wiley

    Professor Valentín Cuervas-Mons, Jordi Carratalà

  131. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia

    Article • Journal of Antimicrobial Chemotherapy, August 2018, Oxford University Press (OUP)

    Jordi Carratalà

  132. Toxoplasmosis in Transplant Recipients, Europe, 2010–2014

    Article • Emerging Infectious Diseases, August 2018, Centers for Disease Control and Prevention (CDC)

    Jordi Carratalà

  133. Twenty-Year Secular Trends in Infective Endocarditis in a Teaching Hospital

    Article • Open Forum Infectious Diseases, July 2018, Oxford University Press (OUP)

    Jordi Carratalà

  134. Current etiology, clinical features and outcomes of bacteremia in older patients with solid tumors

    Article • Journal of Geriatric Oncology, July 2018, Elsevier

    Maite Antonio, Jordi Carratalà

  135. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection

    Article • New England Journal of Medicine, June 2018, New England Journal of Medicine (NEJM/MMS)

    Jordi Carratalà

  136. Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era

    Article • Clinical & Translational Oncology, June 2018, Springer Science + Business Media

    Jordi Carratalà

  137. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction)

    Article • Clinical Microbiology and Infection, June 2018, Elsevier

    Jordi Carratalà

  138. Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial

    Article • Clinical Microbiology and Infection, June 2018, Elsevier

    Jordi Carratalà

  139. Risk Factors for Treatment Failure and Mortality among Hospitalised Patients with Complicated Urinary Tract Infection: A Multicentre Retrospective Cohort Study, RESCUING Study Group

    Article • Clinical Infectious Diseases, May 2018, Oxford University Press (OUP)

    Jordi Carratalà

  140. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT)

    Article • Trials, May 2018, Springer Science + Business Media

    Jordi Carratalà

  141. Predictive factors for early- and late-onset surgical site infections in patients undergoing elective colorectal surgery. A multicentre, prospective, cohort study

    Article • Journal of Hospital Infection, May 2018, Elsevier

    Jordi Carratalà

  142. Mortality risk factors among non-ICU patients with nosocomial vascular catheter-related bloodstream infections: a prospective cohort study

    Article • Journal of Hospital Infection, May 2018, Elsevier

    Jordi Carratalà

  143. A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients

    Article • Clinical Infectious Diseases, April 2018, Oxford University Press (OUP)

    Jordi Carratalà

  144. Mechanical Thrombectomy for Patients With Infective Endocarditis and Ischemic Large-Vessel Stroke

    Article • Clinical Infectious Diseases, April 2018, Oxford University Press (OUP)

    Jordi Carratalà

  145. Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study

    Article • BMJ Open, April 2018, BMJ

    Jordi Carratalà

  146. Clinical impact of culture-positive preservation fluid on solid organ transplantation: A systematic review and meta-analysis

    Article • Transplantation Reviews, April 2018, Elsevier

    Jordi Carratalà

  147. Control of endemic multidrug-resistant Gram-negative bacteria after removal of sinks and implementing a new water-safe policy in an intensive care unit

    Article • Journal of Hospital Infection, March 2018, Elsevier

    Jordi Carratalà

  148. Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors

    Article • Transplantation, February 2018, Wolters Kluwer Health

    Jordi Carratalà

  149. Traveler’s Diarrhea Recommendations for Solid Organ Transplant Recipients and Donors

    Article • Transplantation, February 2018, Wolters Kluwer Health

    Jordi Carratalà

  150. Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

    Article • Clinical Microbiology and Infection, February 2018, Elsevier

    Jordi Carratalà

  151. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

    Article • Journal of Infection, January 2018, Elsevier

    Jordi Carratalà

  152. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Article • Transplantation Reviews, January 2018, Elsevier

    Jordi Carratalà

  153. Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection

    Article • Journal of Antimicrobial Chemotherapy, December 2017, Oxford University Press (OUP)

    Jordi Carratalà

  154. The Alere BinaxNOW Pneumococcal Urinary Antigen Test: Diagnostic Sensitivity for Adult Pneumococcal Pneumonia and Relationship to Specific Serotypes

    Article • Journal of Clinical Microbiology, December 2017, ASM Journals

    Jordi Carratalà

  155. Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia

    Article • Expert Opinion on Pharmacotherapy, December 2017, Taylor & Francis

    Jordi Carratalà

  156. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial

    Article • The Lancet Haematology, December 2017, Elsevier

    Jordi Carratalà

  157. Polymicrobial Bloodstream Infections in Cancer Patients: Incidence, Risk Factors, and Outcomes

    Article • PLoS ONE, October 2017, PLOS

    Jordi Carratalà

  158. Predictors for individual patient antibiotic treatment effect in hospitalized community-acquired pneumonia patients

    Article • Clinical Microbiology and Infection, October 2017, Elsevier

    Jordi Carratalà

  159. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients

    Article • Journal of Antimicrobial Chemotherapy, September 2017, Oxford University Press (OUP)

    Jordi Carratalà

  160. Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis

    Article • Clinical Microbiology and Infection, September 2017, Elsevier

    Jordi Carratalà

  161. Manejo de la infección y la neutropenia febril en el paciente con cáncer sólido

    Article • Enfermedades Infecciosas y Microbiología Clínica, August 2017, Elsevier

    Jordi Carratalà

  162. Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study

    Article • Transplant International, July 2017, Wiley

    Jordi Carratalà

  163. Pharmacotherapy for community-acquired pneumonia in the elderly

    Article • Expert Opinion on Pharmacotherapy, June 2017, Taylor & Francis

    Jordi Carratalà

  164. Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia

    Article • Antimicrobial Agents and Chemotherapy, June 2017, ASM Journals

    Jordi Carratalà

  165. Current outcomes and predictors of treatment failure in patients with surgical site infection after elective colorectal surgery. A multicentre prospective cohort study

    Article • Journal of Infection, June 2017, Elsevier

    Dr Elena Espejo, Jordi Carratalà

  166. Healthcare-Associated Mycobacterium bovis–Bacille Calmette-Guérin (BCG) Infection in Cancer Patients Without Prior BCG Instillation

    Article • Clinical Infectious Diseases, May 2017, Oxford University Press (OUP)

    Jordi Carratalà

  167. Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance

    Article • Journal of Clinical Virology, May 2017, Elsevier

    Jordi Carratalà

  168. Risk factors and outcomes of organ-space surgical site infections after elective colon and rectal surgery

    Article • Antimicrobial Resistance and Infection Control, April 2017, Springer Science + Business Media

    Jordi Carratalà

  169. Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis

    Article • Clinical Infectious Diseases, February 2017, Oxford University Press (OUP)

    Jordi Carratalà

  170. Characteristics, aetiology, antimicrobial resistance and outcomes of bacteraemic cholangitis in patients with solid tumours: A prospective cohort study

    Article • Journal of Infection, February 2017, Elsevier

    Maite Antonio, Jordi Carratalà

  171. Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a...

    Article • BMJ Open, January 2017, BMJ

    Jordi Carratalà

  172. Antibiotic stewardship in community-acquired pneumonia

    Article • Expert Review of Anti-infective Therapy, December 2016, Taylor & Francis

    Jordi Carratalà

  173. Solithromycin for the treatment of community-acquired bacterial pneumonia

    Article • Expert Review of Respiratory Medicine, October 2016, Taylor & Francis

    Jordi Carratalà

  174. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia

    Article • Journal of Antimicrobial Chemotherapy, October 2016, Oxford University Press (OUP)

    Jordi Carratalà

  175. Etiology, Incidence, and Impact of Preservation Fluid Contamination in Liver Transplantation

    Article • PLoS ONE, August 2016, PLOS

    Jordi Carratalà

  176. Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

    Article • Clinical Infectious Diseases, August 2016, Oxford University Press (OUP)

    Jordi Carratalà

  177. Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients

    Article • Respirology, July 2016, Wiley

    Jordi Carratalà

  178. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

    Article • Clinical Infectious Diseases, July 2016, Oxford University Press (OUP)

    Jordi Carratalà

  179. Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Article • Transplantation Reviews, July 2016, Elsevier

    Jordi Carratalà

  180. Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study

    Article • American Journal of Transplantation, July 2016, Elsevier

    Jordi Carratalà

  181. Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING)

    Article • BMJ Open, July 2016, BMJ

    Jordi Carratalà

  182. Declining mortality among hospitalized patients with community-acquired pneumonia

    Article • Clinical Microbiology and Infection, June 2016, Elsevier

    Jordi Carratalà

  183. Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study

    Article • American Journal of Transplantation, May 2016, Wiley

    Julio Pascual, Jordi Carratalà

  184. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients

    Article • Journal of Antimicrobial Chemotherapy, May 2016, Oxford University Press (OUP)

    Jordi Carratalà

  185. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis

    Article • Liver Transplantation, March 2016, Wiley

    Jordi Carratalà

  186. Biomarkers for predicting short-term mortality in community-acquired pneumonia: A systematic review and meta-analysis

    Article • Journal of Infection, March 2016, Elsevier

    Dr Jorge Acosta-Reyes, Jordi Carratalà

  187. Bloodstream infections in patients with solid tumors

    Article • Virulence, February 2016, Taylor & Francis

    Jordi Carratalà

  188. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis

    Article • Influenza and Other Respiratory Viruses, February 2016, Wiley

    Dr Allison McGeer, Kamran Lankarani, Dr CATIA CILLONIZ, Jordi Carratalà

  189. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies

    Article • Clinical Microbiology and Infection, February 2016, Elsevier

    Jordi Carratalà

  190. Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study

    Article • American Journal of Transplantation, February 2016, Elsevier

    Jordi Carratalà

  191. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Article • Hepatology, January 2016, Wolters Kluwer Health

    Jordi Carratalà

  192. Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review

    Article • BMC Infectious Diseases, December 2015, Springer Science + Business Media

    Professor Luís Filipe Azevedo, Jordi Carratalà

  193. Executive summary. Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Mic...

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2015, Elsevier

    Jordi Carratalà

  194. Factors influencing mortality in solid organ transplant recipients with bloodstream infection

    Article • Clinical Microbiology and Infection, December 2015, Elsevier

    Jordi Carratalà

  195. Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) a...

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2015, Elsevier

    Jordi Carratalà

  196. Effect of delaying prophylaxis against CMV in D+/R− solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

    Article • Journal of Infection, November 2015, Elsevier

    Jordi Carratalà

  197. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe

    Article • Clinical Microbiology and Infection, November 2015, Elsevier

    Jordi Carratalà

  198. EDUCAP Trial: Education Reduces Healthcare Use in CAP

    Article • PLoS ONE, October 2015, PLOS

    Jordi Carratalà

  199. Effect of long‐term prophylaxis in the development of cytomegalovirus‐specific T‐cell immunity in D+/R− solid organ transplant recipients

    Article • Transplant Infectious Disease, August 2015, Wiley

    Jordi Carratalà

  200. A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains

    Article • Clinical Microbiology and Infection, July 2015, Elsevier

    Dr Ferran Sanchez-Reus, Jordi Carratalà

  201. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection

    Article • Clinical Microbiology and Infection, June 2015, Elsevier

    Jordi Carratalà

  202. Causes of Death in Invasive Aspergillosis Patients

    Article • PLoS ONE, March 2015, PLOS

    Jordi Carratalà

  203. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

    Article • BMJ Open, March 2015, BMJ

    Dr Elena Espejo, Jordi Carratalà

  204. Extensively Drug-Resistant Pseudomonas aeruginosa Bacteremia in Solid Organ Transplant Recipients

    Article • Transplantation, March 2015, Wolters Kluwer Health

    Jordi Carratalà

  205. The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

    Article • BMJ Open, January 2015, BMJ

    Jordi Carratalà

  206. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

    Article • Annals of Oncology, January 2015, Elsevier

    Jordi Carratalà

  207. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

    Article • Journal of Hepatology, January 2015, Elsevier

    Jordi Carratalà

  208. Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case–control study

    Article • Clinical Microbiology and Infection, January 2015, Elsevier

    Jordi Carratalà

  209. Environmental variables associated with an increased risk of invasive aspergillosis

    Article • Clinical Microbiology and Infection, November 2014, Elsevier

    Jordi Carratalà

  210. Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumours

    Article • Journal of Infection, November 2014, Elsevier

    Jordi Carratalà

  211. Donor-transmitted malaria after heart transplant managed successfully with artesunate

    Article • Transplant Infectious Disease, October 2014, Wiley

    Jordi Carratalà

  212. The Electronic Portfolio as a Teaching Complement for Technical Skills in Health Sciences

    Article • Journal of Cases on Information Technology, October 2014, IGI Global

    Jordi Carratalà

  213. Impact of pre-hospital antibiotic use on community-acquired pneumonia

    Article • Clinical Microbiology and Infection, September 2014, Elsevier

    Jordi Carratalà

  214. Influenza and other respiratory virus infections in solid organ transplant recipients

    Article • Clinical Microbiology and Infection, September 2014, Elsevier

    Jordi Carratalà

  215. Multidrug-resistant bacteria in solid organ transplant recipients

    Article • Clinical Microbiology and Infection, September 2014, Elsevier

    Jordi Carratalà

  216. Clinical Features, Etiology and Outcomes of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease

    Article • PLoS ONE, August 2014, PLOS

    Jordi Carratalà

  217. Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial

    Article • Trials, August 2014, Springer Science + Business Media

    Jordi Carratalà

  218. Legionellosis and biologic therapies

    Article • Respiratory Medicine, August 2014, Elsevier

    Jordi Carratalà

  219. Efficacy and Safety of Fosfomycin Plus Imipenem as Rescue Therapy for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Multicenter Clinical Trial

    Article • Clinical Infectious Diseases, July 2014, Oxford University Press (OUP)

    Jordi Carratalà

  220. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia

    Article • Journal of Infection, June 2014, Elsevier

    Jordi Carratalà

  221. Antibiotic resistance in cancer patients

    Article • Expert Review of Anti-infective Therapy, May 2014, Taylor & Francis

    Jordi Carratalà

  222. Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R−): experience from the RESITRA-REIPI cohort

    Article • Transplant Infectious Disease, May 2014, Wiley

    Jordi Carratalà

  223. Bloodstream Infections in Patients With Solid Tumors

    Article • Medicine, May 2014, Wolters Kluwer Health

    Jordi Carratalà

  224. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

    Article • The Lancet Respiratory Medicine, May 2014, Elsevier

    Dr Allison McGeer, Dr CATIA CILLONIZ, Kamran Lankarani, Jordi Carratalà

  225. Candidaarteritis occurring in a liver transplant recipient

    Article • Transplant Infectious Disease, April 2014, Wiley

    Jordi Carratalà

  226. Fatal retroperitoneal gas gangrene complicating colonoscopic polypectomy without bowel perforation in a healthy adult

    Article • Endoscopy, March 2014, Thieme Publishing Group

    Jordi Carratalà

  227. Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients

    Article • Bone Marrow Transplantation, March 2014, Springer Science + Business Media

    Jordi Carratalà

  228. Pneumonia in solid organ transplant recipients: a prospective multicenter study

    Article • Transplant Infectious Disease, March 2014, Wiley

    Jordi Carratalà

  229. Management of community-acquired pneumonia in older adults

    Article • Therapeutic Advances in Infectious Disease, January 2014, SAGE Publications

    Jordi Carratalà

  230. Características clínicas y pronóstico de la neumonía adquirida en la comunidad causada por Staphylococcus aureus resistente a la meticilina

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2014, Elsevier

    Jordi Carratalà

  231. Molecular Epidemiology of Nontypeable Haemophilus influenzae in Community-Acquired Pneumonia

    Article • PLoS ONE, December 2013, PLOS

    Jordi Carratalà

  232. Risk Factors and Outcomes of Bacteremia Caused by Drug-Resistant ESKAPE Pathogens in Solid-Organ Transplant Recipients

    Article • Transplantation, November 2013, Wolters Kluwer Health

    Jordi Carratalà

  233. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients

    Article • Supportive Care in Cancer, October 2013, Springer Science + Business Media

    Jordi Carratalà

  234. Statin Use and Candidemia Outcomes in Adults

    Article • PLoS ONE, October 2013, PLOS

    Jordi Carratalà

  235. Executive summary. Management of influenza infection in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbi...

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2013, Elsevier

    Jordi Carratalà

  236. Management of influenza infection in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and t...

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2013, Elsevier

    Jordi Carratalà

  237. Increased Bloodstream Infections in Cancer Patients Due to Enterococcus faecium (2006-2012)

    Article • PLoS ONE, September 2013, PLOS

    Jordi Carratalà

  238. Community-acquired pneumonia during the first post-pandemic influenza season: A prospective, multicentre cohort study

    Article • Journal of Infection, September 2013, Elsevier

    Jordi Carratalà

  239. Prediction of prognosis by markers in community-acquired pneumonia

    Article • Expert Review of Anti-infective Therapy, September 2013, Taylor & Francis

    Jordi Carratalà

  240. Pathogenesis of invasive fungal infections

    Article • Current Opinion in Infectious Diseases, June 2013, Wolters Kluwer Health

    Jordi Carratalà

  241. Advances in antibiotic therapy for community-acquired pneumonia

    Article • Current Opinion in Pulmonary Medicine, May 2013, Wolters Kluwer Health

    Jordi Carratalà

  242. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients

    Article • Clinical Microbiology and Infection, May 2013, Elsevier

    Jordi Carratalà

  243. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia

    Article • Journal of Infection, May 2013, Elsevier

    Jordi Carratalà

  244. Rainfall and Legionella Pneumonia Risk

    Article • PLoS ONE, April 2013, PLOS

    Jordi Carratalà

  245. Estimating Pneumococcal Pneumonia Burden in Adults: A Meta-Analysis

    Article • PLoS ONE, April 2013, PLOS

    Jordi Carratalà

  246. Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome

    Article • Clinical Microbiology and Infection, February 2013, Elsevier

    Jordi Carratalà

  247. Clinical Features, Etiology, and Outcomes of Community-Acquired Pneumonia in Patients With Diabetes Mellitus

    Article • Medicine, January 2013, Wolters Kluwer Health

    Jordi Carratalà

  248. Community-Acquired Legionella pneumophila Pneumonia

    Article • Medicine, January 2013, Wolters Kluwer Health

    Jordi Carratalà

  249. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia

    Article • Journal of Infection, January 2013, Elsevier

    Jordi Carratalà